查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829648

2025年全球连续性肾臟替代疗法市场报告

Continuous Renal Replacement Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，连续性肾臟替代疗法 (CRRT) 市场快速扩张，市场规模从 2024 年的 15.7 亿美元成长至 2025 年的 17.3 亿美元，复合年增长率为 10.5%。预测期内的增长归因于对先进 CRRT 设备的需求不断增长、急性肾损伤发病率上升、医疗应用日益增多、合併症患病率高以及持续的研发投入。

预计未来几年，连续性肾臟替代疗法 (CRRT) 市场规模将快速成长，到 2029 年将达到 25.5 亿美元，复合年增长率为 10.2%。预测期内的增长归因于慢性肾臟病率的上升、糖尿病患病率的上升、重症监护病房 (ICU) 入院人数的增加、医疗基础设施投资的增加以及儿科护理应用的不断扩展。预测期内的主要趋势包括快速发展、新技术的推出、技术进步、产品创新以及技术先进的 CRRT 产品。

持续性肾臟替代疗法 (CRRT) 是一种透析方法，透过分阶段、持续的血液滤过来调节液体、电解质和废物水平，适用于血流动力学不稳定的急性肾损伤 (AKI)重症患者。 CRRT 在管理液体超负荷方面发挥重要作用，尤其适用于心血管系统不稳定、无法耐受间歇性血液血液透析机快速清除液体的重症患者。

连续性肾臟替代疗法 (CRRT) 市场的关键产品是系统和耗材。连续性肾臟替代疗法 (CRRT) 系统是用于治疗急性肾重症患者的专用医疗设备。它们采用不同的模式提供各种肾臟和非肾臟治疗，例如慢速连续超过滤(SCUF)、连续性静脉-血液透析机(CVVHD) 和连续性静脉-静脉血液滤过 (CVVHDF)。这些疗法可在各种环境中（包括医院、门诊护理中心和居家照护机构）用于成人、儿童和新生儿。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供持续性肾臟替代疗法（CRT）的市场统计数据，例如持续性肾臟替代疗法（CRT）行业的全球市场规模、各地区市场份额、竞争对手的市场份额、详细的持续性肾臟替代疗法（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）细分市场、市场趋势和商机，以及您在持续性肾臟（CRT）本持续性肾臟替代疗法市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

我们预测未来五年该市场将成长10.2%，较我们先前对该市场的预测略有下降0.8%。下降的主要原因是美国与其他国家之间的关税影响。这可能会透过对来自义大利和中国等关键地区的高通量血液过滤器和无菌透析液袋征收关税直接影响美国，从而导致重症加护能力下降，并增加治疗急性肾损伤的成本。由于互惠关税以及不断升级的贸易摩擦和限制对全球经济和贸易的负面影响，这种影响也可能更为广泛。

慢性肾臟病(CKD) 盛行率的不断上升预计将在未来几年推动连续性肾臟替代疗法 (CRRT) 市场的扩张。 CKD 是一种长期疾病，其特征是肾功能逐渐下降，损害器官过滤血液中废物的能力。 CKD 病例的增加主要是由于生活方式的改变、人口老化以及糖尿病和高血压盛行率的上升等因素。连续性肾臟替代疗法 (CRRT) 通常用于治疗 CKD 的急性发作和併发症，帮助调节体液平衡并持续清除代谢废物。例如，2024 年 5 月，美国疾病管制与预防中心 (CDC) 报告称，美国有超过 3,550 万成年人（约七分之一）患有 CKD。令人惊讶的是，其中近 90% 的人并不知道自己的病情，这凸显了美国在早期发现和宣导活动方面存在巨大差距。

连续性肾臟替代疗法 (CRRT) 市场的主要企业专注于为透析患者开发先进的肾臟治疗解决方案，旨在改善治疗效果、提高患者预后并减少与传统透析相关的併发症。与传统透析不同，这种疗法是持续进行的（通常每天 24 小时）并且对身体温和，特别适合患有急性肾损伤或严重疾病的患者。例如，2023 年 1 月，美国提供急诊和外科服务的医疗机构佩科尼克湾医疗中心 (PBMC) 为透析患者推出了新的肾臟治疗选择。该疗法旨在为健康状况使标准透析难以忍受的患者提供更舒适的透析体验。 CRRT 比传统透析的给药更缓慢，可减轻重症患者的压力。

2024年8月，以生产医疗产品而闻名的美国医疗保健公司百特国际（Baxter International）以38亿美元收购了凯雷集团（The Carlyle Group）。透过此次收购，凯雷集团增强了其在肾臟护理领域的投资组合，并致力于满足慢性肾臟病病患者对创新透析产品和服务日益增长的需求。凯雷集团是一家专注于持续性肾臟替代疗法（CRT）的美国投资公司。

连续性肾臟替代疗法市场的主要参与者包括美敦力公司、费森尤斯医疗股份公司、旭化成株式会社、东丽株式会社、百特国际公司、B. Braun Melsungen AG、泰尔Terumo Corporation TechnologiesS. Srl、宁波天一医疗器材有限公司、Cytosorbents Corporation、Kawasumi Laboratories Inc.、Medica SpA、Infomed SA、Medites Pharma Spol.SRO、日机装株式会社、Kawasumi Laboratories、Medica SpA、Infomed SA、Medites Pharm Spol.Ltd.、Medcomp Systems Ltd. 等。

2024年，北美是连续性肾臟替代疗法市场规模最大的地区。预计亚太地区将成为预测期内成长最快的地区。连续性肾臟替代疗法市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

连续性肾臟替代疗法市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、英国、美国、义大利和西班牙。

连续性肾臟替代疗法 (CRRT) 市场由提供急性血液透析机、水分离和液体管理等服务的营业单位所获得的收益构成。市场价值包括服务提供者销售或包含在其服务产品中的相关产品的价值。连续性肾臟替代疗法市场还包括透析导管、透析液、止血剂和气道系统的销售。该市场的价值为“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球连续性肾臟替代疗法：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球连续性肾臟替代治疗市场：成长率分析
  • 全球连续性肾臟替代疗法市场表现：规模与成长，2019-2024
  • 全球连续性肾臟替代疗法市场预测：规模与成长，2024-2029，2034
  • 全球连续性肾臟替代疗法：总目标市场（TAM）

第六章 市场细分

  • 全球连续性肾臟替代治疗市场（依产品、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 系统
  • 耗材
  • 全球连续性肾臟替代疗法市场（按治疗类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 肾
  • 非肾臟
  • 全球连续性肾臟替代治疗市场（按模式、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 慢速连续超过滤（SCUF）
  • 持续性静脉-静脉血液滤过（CVVH）
  • 持续性血液透析机（CVVHD）
  • 持续性静脉-静脉血液透析滤过（CVVHDF）
  • 全球连续性肾臟替代治疗市场（按年龄层、绩效及预测）2019-2024 年、2024-2029 年、2034 年
  • 成人
  • 小儿科或新生儿
  • 全球连续性肾臟替代治疗市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊治疗
  • 居家护理
  • 全球连续性肾臟替代疗法市场：按系统、类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 血液过滤器
  • CRRT机
  • 血管组
  • 全球连续性肾臟替代治疗市场：按耗材（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 透析液
  • 补充品
  • 导管
  • 血统集

第七章 区域和国家分析

  • 全球连续性肾臟替代治疗市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球连续性肾臟替代治疗市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 连续性肾臟替代疗法市场：竞争格局
  • 连续性肾臟替代治疗市场：公司简介
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Medical Care AG & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • NxStage Medical Inc.
  • Hillrom Holdings Inc.
  • Gambro AB
  • JMS Co. Ltd.
  • Quanta Dialysis Technologies Ltd.
  • Bellco Srl
  • Ningbo Tianyi Medical Devices Co. Ltd.
  • Cytosorbents Corporation
  • Kawasumi Laboratories Inc.
  • Medica SpA
  • Infomed SA
  • Medites Pharma Spol. SRO

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年持续性肾臟替代疗法市场：提供新机会的国家
  • 2029年持续性肾臟替代治疗市场：细分市场带来新机会
  • 2029年连续性肾臟替代疗法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29883u

Continuous renal replacement therapy (CRRT) is a form of dialysis that provides gradual, ongoing blood filtration to help regulate levels of fluids, electrolytes, and waste products in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It plays a crucial role in managing fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal through intermittent hemodialysis due to cardiovascular instability.

The primary products in the continuous renal replacement therapy market are systems and consumables. A continuous renal replacement therapy (CRRT) system is a specialized medical device utilized in treating critically ill patients with AKI or other renal conditions. It offers various renal and non-renal therapies using different modalities such as slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These therapies are administered to adults, pediatrics, and neonates in various settings including hospitals, ambulatory care centers, and homecare setups.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The continuous renal replacement therapy market research report is one of a series of new reports from The Business Research Company that provides continuous renal replacement therapy market statistics, including continuous renal replacement therapy industry global market size, regional shares, competitors with a continuous renal replacement therapy market share, detailed continuous renal replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the continuous renal replacement therapy industry. This continuous renal replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous renal replacement therapy market size has grown rapidly in recent years. It will grow from $1.57 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased demand for advanced CRRT devices, an increase in the prevalence of incidence of acute kidney injury, a rise in the number of medical applications, a high prevalence of co-morbidities, and continuous research and development.

The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.55 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing incidences of chronic kidney diseases, rising prevalence of diabetes, a growing number of ICU admissions, rising investments in healthcare infrastructure, and expanding applications in pediatric care. Major trends in the forecast period include rapid advancements, launches of new technologies, technological advancements, product innovation, and technologically advanced CRRT products.

The forecast of 10.2% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on high-flux hemofilters and sterile dialysis solution bags, sourced from key regions such as Italy and China, which could lead to reduced critical care capacity and increased costs for acute kidney injury treatment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of chronic kidney disease (CKD) is expected to drive the expansion of the continuous renal replacement therapy (CRRT) market in the future. CKD is a long-term condition in which kidney function gradually declines, impairing the organ's ability to filter waste from the blood. This increase in CKD cases is largely attributed to factors such as lifestyle changes, an aging population, and higher rates of diabetes and hypertension. Continuous renal replacement therapy is commonly used to manage acute exacerbations or complications of CKD, helping to regulate fluid balance and remove metabolic waste continuously. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that more than 35.5 million adults in the United States-about 1 in 7-are affected by CKD. Alarmingly, nearly 90% of these individuals are unaware of their condition, highlighting the significant gap in early detection and awareness efforts in the U.S.

Leading companies in the continuous renal replacement therapy (CRRT) market are concentrating on developing advanced renal therapy solutions for dialysis patients, aiming to improve treatment effectiveness, enhance patient outcomes, and reduce complications linked to conventional dialysis methods. Unlike traditional dialysis, this therapy runs continuously-usually over a 24-hour period-and is gentler on the body, making it particularly suitable for patients with acute kidney injuries or severe medical conditions. For example, in January 2023, Peconic Bay Medical Center (PBMC), a U.S.-based healthcare facility offering emergency and surgical services, introduced a new renal therapy option for dialysis patients. This therapy is designed to offer greater comfort to patients who may not tolerate standard dialysis due to their health conditions. CRRT is administered more gradually than traditional dialysis, which helps reduce stress on critically ill patients.

In August 2024, Baxter International Inc., a U.S.-based healthcare company known for producing medical products, acquired The Carlyle Group Inc. for $3.8 billion. This acquisition allows Carlyle Group to strengthen its portfolio in renal care, positioning itself to capitalize on the increasing demand for innovative dialysis products and services for patients with chronic kidney disease. The Carlyle Group Inc. is a U.S.-based investment firm with a focus on continuous renal replacement therapy.

Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.

North America was the largest region in the continuous renal replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous renal replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The continuous renal replacement therapy (CRRT) market consists of revenues earned by entities by providing services such as acute hemodialysis, aquapheresis, and fluid management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous renal replacement therapy market also includes sales of dialysis catheters, dialysates, hemostatic agents, and airway clearance systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Renal Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous renal replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous renal replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous renal replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: System; Consumables
  • 2) By Therapy: Renal; Non-Renal
  • 3) By Modality: Slow Continuous Ultra-Filtration (SCUF); Continuous Venovenous Hemofiltration (CVVH); Continuous Venovenous Hemodialysis (CVVHD); Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 4) By Age Group: Adults; Pediatrics Or Neonates
  • 5) By End-Users: Hospitals; Ambulatory Care; Homecare
  • Subsegments:
  • 1) By System: Hemofilters; CRRT Machines; Blood Tubing Sets
  • 2) By Consumables: Dialysate Solutions; Replacement Fluids; Catheters; Bloodline Sets
  • Companies Mentioned: Medtronic Plc; Fresenius Medical Care AG & Co. KGaA; Asahi Kasei Corporation; Toray Industries Inc.; Baxter International Inc.; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; NxStage Medical Inc.; Hillrom Holdings Inc.; Gambro AB; JMS Co. Ltd.; Quanta Dialysis Technologies Ltd.; Bellco S.r.l.; Ningbo Tianyi Medical Devices Co. Ltd.; Cytosorbents Corporation; Kawasumi Laboratories Inc.; Medica S.p.A.; Infomed SA; Medites Pharma Spol. S.R.O; Nikkiso Co. Ltd.; Anjue Medical Equipment Co. Ltd.; Medcomp Systems Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Continuous Renal Replacement Therapy Market Characteristics

3. Continuous Renal Replacement Therapy Market Trends And Strategies

4. Continuous Renal Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Continuous Renal Replacement Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Continuous Renal Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Continuous Renal Replacement Therapy Market Growth Rate Analysis
  • 5.4. Global Continuous Renal Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Continuous Renal Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Continuous Renal Replacement Therapy Total Addressable Market (TAM)

6. Continuous Renal Replacement Therapy Market Segmentation

  • 6.1. Global Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • System
  • Consumables
  • 6.2. Global Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Renal
  • Non-Renal
  • 6.3. Global Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.4. Global Continuous Renal Replacement Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adults
  • Pediatrics Or Neonates
  • 6.5. Global Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Care
  • Homecare
  • 6.6. Global Continuous Renal Replacement Therapy Market, Sub-Segmentation Of System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemofilters
  • CRRT Machines
  • Blood Tubing Sets
  • 6.7. Global Continuous Renal Replacement Therapy Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dialysate Solutions
  • Replacement Fluids
  • Catheters
  • Bloodline Sets

7. Continuous Renal Replacement Therapy Market Regional And Country Analysis

  • 7.1. Global Continuous Renal Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Continuous Renal Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 8.1. Asia-Pacific Continuous Renal Replacement Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Continuous Renal Replacement Therapy Market

  • 9.1. China Continuous Renal Replacement Therapy Market Overview
  • 9.2. China Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Continuous Renal Replacement Therapy Market

  • 10.1. India Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Continuous Renal Replacement Therapy Market

  • 11.1. Japan Continuous Renal Replacement Therapy Market Overview
  • 11.2. Japan Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Continuous Renal Replacement Therapy Market

  • 12.1. Australia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Continuous Renal Replacement Therapy Market

  • 13.1. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Continuous Renal Replacement Therapy Market

  • 14.1. South Korea Continuous Renal Replacement Therapy Market Overview
  • 14.2. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Continuous Renal Replacement Therapy Market

  • 15.1. Western Europe Continuous Renal Replacement Therapy Market Overview
  • 15.2. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Continuous Renal Replacement Therapy Market

  • 16.1. UK Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Continuous Renal Replacement Therapy Market

  • 17.1. Germany Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Continuous Renal Replacement Therapy Market

  • 18.1. France Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Continuous Renal Replacement Therapy Market

  • 19.1. Italy Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Continuous Renal Replacement Therapy Market

  • 20.1. Spain Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Continuous Renal Replacement Therapy Market

  • 21.1. Eastern Europe Continuous Renal Replacement Therapy Market Overview
  • 21.2. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Continuous Renal Replacement Therapy Market

  • 22.1. Russia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Continuous Renal Replacement Therapy Market

  • 23.1. North America Continuous Renal Replacement Therapy Market Overview
  • 23.2. North America Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Continuous Renal Replacement Therapy Market

  • 24.1. USA Continuous Renal Replacement Therapy Market Overview
  • 24.2. USA Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Continuous Renal Replacement Therapy Market

  • 25.1. Canada Continuous Renal Replacement Therapy Market Overview
  • 25.2. Canada Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Continuous Renal Replacement Therapy Market

  • 26.1. South America Continuous Renal Replacement Therapy Market Overview
  • 26.2. South America Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Continuous Renal Replacement Therapy Market

  • 27.1. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Continuous Renal Replacement Therapy Market

  • 28.1. Middle East Continuous Renal Replacement Therapy Market Overview
  • 28.2. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Continuous Renal Replacement Therapy Market

  • 29.1. Africa Continuous Renal Replacement Therapy Market Overview
  • 29.2. Africa Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Continuous Renal Replacement Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Continuous Renal Replacement Therapy Market Competitive Landscape
  • 30.2. Continuous Renal Replacement Therapy Market Company Profiles
    • 30.2.1. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Fresenius Medical Care AG & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Continuous Renal Replacement Therapy Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Terumo Corporation
  • 31.3. Nipro Corporation
  • 31.4. NxStage Medical Inc.
  • 31.5. Hillrom Holdings Inc.
  • 31.6. Gambro AB
  • 31.7. JMS Co. Ltd.
  • 31.8. Quanta Dialysis Technologies Ltd.
  • 31.9. Bellco S.r.l.
  • 31.10. Ningbo Tianyi Medical Devices Co. Ltd.
  • 31.11. Cytosorbents Corporation
  • 31.12. Kawasumi Laboratories Inc.
  • 31.13. Medica S.p.A.
  • 31.14. Infomed SA
  • 31.15. Medites Pharma Spol. S.R.O

32. Global Continuous Renal Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Renal Replacement Therapy Market

34. Recent Developments In The Continuous Renal Replacement Therapy Market

35. Continuous Renal Replacement Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Continuous Renal Replacement Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Continuous Renal Replacement Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Continuous Renal Replacement Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer